B
Bin Liu
Researcher at Kunming University of Science and Technology
Publications - 6
Citations - 1365
Bin Liu is an academic researcher from Kunming University of Science and Technology. The author has contributed to research in topics: Proinflammatory cytokine & Virus. The author has an hindex of 3, co-authored 6 publications receiving 855 citations.
Papers
More filters
Journal ArticleDOI
Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions
Zifeng Yang,Zifeng Yang,Zhiqi Zeng,Ke Wang,Sook San Wong,Sook San Wong,Wenhua Liang,Mark Zanin,Mark Zanin,Liu Peng,Xudong Cao,Zhongqiang Gao,Zhitong Mai,Jingyi Liang,Xiaoqing Liu,Shiyue Li,Yimin Li,Feng Ye,Wei-jie Guan,Yifan Yang,Fei Li,Shengmei Luo,Yuqi Xie,Bin Liu,Zhoulang Wang,Shaobo Zhang,Yaonan Wang,Nanshan Zhong,Jianxing He +28 more
TL;DR: The implementation of control measures on January 23 2020 was indispensable in reducing the eventual COVID-19 epidemic size, and the dynamic SEIR model, trained on the 2003 SARS data, was effective in predicting the epidemic peaks and sizes.
Journal ArticleDOI
Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.
Qinhai Ma,Weiqi Pan,Run-Feng Li,Bin Liu,Chufang Li,Yuqi Xie,Zhoulang Wang,Jin Zhao,Haiming Jiang,Jicheng Huang,Yongxia Shi,Jun Dai,Kui Zheng,Xiaobo Li,Zifeng Yang +14 more
TL;DR: Findings indicate that LS could inhibit SARS-CoV-2 virus infection via downregulating the expression of inflammatory cytokines induced virus and regulating the activity of NF-κB/MAPK signaling pathway in vitro, making its promising candidate treatment for controlling COVID-19 disease.
Journal ArticleDOI
Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
Qinhai Ma,Runfeng Li,Weiqi Pan,Wenbo Huang,Bin Liu,Yuqi Xie,Zhoulang Wang,Chufang Li,Haiming Jiang,Jicheng Huang,Yongxia Shi,Jun Dai,Kui Zheng,Xiaobo Li,Min Hui,Li Fu,Zifeng Yang,Zifeng Yang +17 more
TL;DR: Investigation of the antiviral and anti-inflammatory activities of KD-1 against the novel SARS-CoV-2 and H coV-229E indicated that KD- 1 protected against virus and can thus be used as a novel strategy for controlling coronavirus 2019.
Journal ArticleDOI
Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.
Qinhai Ma,Yuqi Xie,Zhoulang Wang,Biao Lei,Ruihan Chen,Bin Liu,Haiming Jiang,Yutao Wang,Qingquan Liu,Zifeng Yang +9 more
TL;DR: In this paper, the clinical efficacy of ReDuNing injection in patients with COVID-19 and its antiviral activity against SARS-CoV-2 in vitro was evaluated.
Journal ArticleDOI
Prediction of potential for organ donation after circulatory death in neurocritical patients
Guixing Xu,Zhiyong Guo,Wenhua Liang,Erye Xin,Bin Liu,Ye Xu,Zhongqin Luan,Paul M. Schroder,Martí Manyalich,Dicken S.C. Ko,Xiaoshun He +10 more
TL;DR: The C-DCD-Nomogram is superior to the other 3 tools for predicting death within a limited duration after withdrawal of life-sustaining treatment in Chinese neurocritical patients and appears to be a reliable tool identifying potential donors after circulatory death.